Citation

Tan JOA, Koelch M. Child Adolesc. Psychiatry Ment. Health 2008; 2.

Copyright

(Copyright © 2008, Holtzbrinck Springer Nature Publishing Group - BMC)

DOI

10.1186/1753-2000-2-39

PMID

unavailable

Abstract

Research in psychopharmacology for children and adolescents is fraught with ethical problems and tensions. This has practical consequences as it leads to a paucity of the research that is essential to support the treatment of this vulnerable group. In this article, we will discuss some of the ethical issues which are relevant to such research, and explore their implications for both research and standard care. We suggest that finding a way forward requires a willingness to acknowledge and discuss the inherent conflicts between the ethical principles involved. Furthermore, in order to facilitate more, ethically sound psychopharmacology research in children and adolescents, we suggest more ethical analysis, empirical ethics research and ethics input built into psychopharmacological research design. © 2008 Tan and Koelch; licensee BioMed Central Ltd.

Language: en

Keywords

human rights; human; suicide; psychotherapy; depression; psychosis; patient safety; clinical trial; article; drug legislation; health care quality; informed consent; fluoxetine; priority journal; medical decision making; psychotropic agent; psychopharmacology; drug industry; medical research; drug cost; professional standard; legal liability; drug; medical profession; patent; research ethics; clinical competence; reimbursement; psychological well being